SK pharmteco s acquisition of American genetic medicine developer CBM has given the Korean firm an advantage in the principal genetic medicine markets in the U.S. and Europe, according to SK Group.
/PRNewswire/ SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that.
/PRNewswire/ SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that.
FRANKFURT - Samsung Biologics and other biotechnology companies in Korea will showcase their technologies and seek more business opportunities with global buyers at this year s CPhI bio pharmaceutical exhibition, according to the companies, Monday. The CPhI is an annual exhibition in the bio pharmaceutical industry held in Europe. This year s event will be held for three days from Tuesday to Thursday in the German city of Frankfurt. The event organizer expects that this year s event will attract more than 40,000 visitors with more than 2,500 companies from 170 countries participating.